Home/Filings/4/0001062993-24-009082
4//SEC Filing

Last Andrew J. 4

Accession 0001062993-24-009082

CIK 0000012208other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 5:53 PM ET

Size

8.7 KB

Accession

0001062993-24-009082

Insider Transaction Report

Form 4
Period: 2024-04-29
Last Andrew J.
EVP, Chief Operating Officer
Transactions
  • Tax Payment

    Bio-Rad A Common Stock

    2024-04-29$277.11/sh357$98,9285,719.888 total
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2024-04-29+1,0006,076.888 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-04-291,0000 total
    Exercise: $0.00Bio-Rad A Common Stock (1,000 underlying)
Footnotes (4)
  • [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
  • [F2]Includes 9.7660 and 27.5220 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2023 and 03/31/2024, respectively.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
  • [F4]On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother

Related Parties

1
  • filerCIK 0001485088

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 5:53 PM ET
Size
8.7 KB